Pharmacyte Biotech Inc (PMCB)

May 23, 2026

PharmaCyte Biotech (PMCB) Edges Higher: Support-Holding Action at $0.81Long Setup Ideas - Newser

May 23, 2026

May 22, 2026

PMCB Q1 2026 Earnings: Pre-Revenue Biotech Reports Negative EPS; Stock Rises on Potential Pipeline Progress - Newser

May 22, 2026

May 22, 2026

PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 22, 2026

May 22, 2026

PharmaCyte Biotech (PMCB) Rallies 5.6% as Biotech Sentiment ImprovesNHNL Divergence - Newser

May 22, 2026

May 22, 2026

PharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Strategic Pipeline ProgressHigh Estimate Range - Newser

May 22, 2026

May 21, 2026

PharmaCyte Biotech Inc. (PMCB) Q1 2026 Earnings: Pre-Revenue Biotech Reports Wider Loss Amid Strategic Pipeline ProgressShared Momentum Picks - Newser

May 21, 2026

May 17, 2026

PharmaCyte Biotech (PMCB) Q1 2026 Earnings: Revenue $N/A, Matching ViewsGuidance Revision Trend - Newser

May 17, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

Apr 27, 2026

PharmaCyte Biotech (PMCB) Stock: Buy or Sell |Risk Report - newser.com

Apr 27, 2026

Apr 26, 2026

PMCB SEC FilingsPharmacyte Biotech Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 26, 2026

Apr 23, 2026

PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN

Apr 23, 2026

Apr 20, 2026

PharmaCyte Biotech (PMCB) Stock Take Profit (Gains) 2026-04-20Trending Social Stocks - Newser

Apr 20, 2026

Apr 13, 2026

Aug Intraday: Is PharmaCyte Biotech Inc a good ESG investment2026 Short Interest & Accurate Trade Setup Notifications - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

PharmaCyte Biotech Operating Margin | PMCB - MLQ.ai

Apr 13, 2026

Apr 13, 2026

EV Market: Should I invest in PharmaCyte Biotech Inc before earningsJobs Report & Weekly High Return Opportunities - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

How liquid is PharmaCyte Biotech Inc stockPortfolio Performance Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Is PharmaCyte Biotech (PMCB) Stock Near Support | Price at $0.69, Up 5.96%Combination Correction - Newser

Apr 13, 2026

Apr 11, 2026

Aug Ideas: What is the Moat Score of PharmaCyte Biotech Inc2026 EndofYear Setup & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Apr 11, 2026

Apr 09, 2026

Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Sentiment Report & Growth Focused Stock Pick Reports - baoquankhu1.vn

Apr 09, 2026

Apr 03, 2026

PharmaCyte Biotech Shareholders Approve Governance and Equity Actions - The Globe and Mail

Apr 03, 2026

Apr 02, 2026

Director Weinstein receives 119,170 stock options at PharmaCyte Biotech (PMCB) - Stock Titan

Apr 02, 2026

Apr 02, 2026

Director at PharmaCyte Biotech (PMCB) gets 119,170 options - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) director awarded 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) director receives 119,170 stock options at $0.67 - Stock Titan

Apr 02, 2026

Apr 02, 2026

PharmaCyte Biotech (PMCB) wins approval for reverse split range and 2M new plan shares - Stock Titan

Apr 02, 2026

Mar 27, 2026

PMCB Stock Chart | PHARMACYTE BIOTECH INC (NASDAQ:PMCB) - ChartMill

Mar 27, 2026

Mar 20, 2026

Insider Sell: How liquid is PharmaCyte Biotech Inc stock2026 Setups & Safe Entry Momentum Tips - baoquankhu1.vn

Mar 20, 2026

Mar 19, 2026

PharmaCyte Biotech, Inc. (PMCB) Q3 2026 10-Q Report: Financial Results, Stock Information, and SEC Filings - Minichart

Mar 19, 2026

Mar 18, 2026

PharmaCyte Biotech (PMCB) logs neutral Form 4 as 10% FEMASYS (FEMY) owner - Stock Titan

Mar 18, 2026

Mar 18, 2026

PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants - Stock Titan

Mar 18, 2026

Mar 17, 2026

PharmaCyte Biotech 10-Q: $0.0M Revenue, $(0.17) EPS (Q3), $(2.41) EPS (YTD) - TradingView

Mar 17, 2026

Mar 17, 2026

PharmaCyte Biotech (NASDAQ: PMCB) details Jan 2026 results and cash runway - Stock Titan

Mar 17, 2026

Mar 14, 2026

PharmaCyte Biotech delays quarterly report filing - MSN

Mar 14, 2026

Mar 12, 2026

Analyzing Prime Medicine (NYSE:PRME) & PharmaCyte Biotech (OTCMKTS:PMCBD) - Defense World

Mar 12, 2026

Mar 10, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Mar 10, 2026

Mar 09, 2026

PharmaCyte Biotech (PMCB) seeks reverse split, equity plan boost at 2026 meeting - Stock Titan

Mar 09, 2026

Mar 07, 2026

Aug Catalysts: Can PharmaCyte Biotech Inc. stock weather global recessionWeekly Profit Summary & Safe Capital Growth Plans - Naître et grandir

Mar 07, 2026

Mar 04, 2026

PMCB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Feb 28, 2026

Technical Analysis - Intellectia AI

Feb 28, 2026

Feb 27, 2026

PharmaCyte Biotech (PMCB) seeks reverse split and 2M share plan boost at virtual meeting - Stock Titan

Feb 27, 2026

Feb 25, 2026

Day Trade: Can PharmaCyte Biotech Inc keep up with sector leadersJuly 2025 Trends & Free Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 25, 2026

Feb 10, 2026

PharmaCyte Biotech (OTCMKTS:PMCBD) Trading 5.9% Higher – Time to Buy? - Defense World

Feb 10, 2026

Feb 09, 2026

Volume Summary: What is SIM Acquisition Corp Is P E ratio telling usJuly 2025 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn

Feb 09, 2026

Feb 05, 2026

Dow Update: Is PharmaCyte Biotech Inc vulnerable to short sellersMarket Risk Summary & Verified Trade Idea Suggestions - baoquankhu1.vn

Feb 05, 2026

Jan 29, 2026

Is PharmaCyte Biotech Inc. trading at a discountWeekly Stock Report & Weekly High Momentum Picks - mfd.ru

Jan 29, 2026